Bio‑artificial Liver — ALEX™ Platform
Inventor & patent holder of the ALEX bio‑artificial liver (PCT US97/22727), featuring an autologous biomatrix that extends hepatocyte viability for extracorporeal support.
Inventor & patent holder of the ALEX bio‑artificial liver (PCT US97/22727), featuring an autologous biomatrix that extends hepatocyte viability for extracorporeal support.
Pioneered the world’s first cell‑based gene graft curing Crigler–Najjar syndrome through minimally invasive hepatocyte infusion.
Developed fiducial‑guided Synchrony® tracking, enabling CyberKnife treatment of moving extra‑cranial tumours.
Created and validated the PEQUOL questionnaire, a prognostic tool for mental and relational well‑being in transplant patients.